Ignite Creation Date:
2024-05-06 @ 7:14 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05947500
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2023-07-13
Brief Title:
Testing the Combination of Two Anticancer Drugs M1774 Tuvusertib and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer MATRiX Trial
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 |
| Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8 |
| Locally Advanced Merkel Cell Carcinoma |
| Metastatic Merkel Cell Carcinoma |
| Refractory Merkel Cell Carcinoma |
| Unresectable Merkel Cell Carcinoma |
Keywords: